Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T02:01:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-10T00:14:10.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-02T18:41:39.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the HHS Vulnerability Disclosure, changing from revision v2.16.6 to v2.16.8.
    Difference
    0.1%
    Check dated 2025-07-26T15:02:14.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.0%
    Check dated 2025-07-19T11:32:27.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours beginning at 9 PM EDT.
    Difference
    0.5%
    Check dated 2025-07-12T07:48:54.000Z thumbnail image

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.